Literature DB >> 12943720

Activation and nuclear translocation of PKCdelta, Pyk2 and ERK1/2 by gonadotropin releasing hormone in HEK293 cells.

Parvaiz Q Farshori1, Bukhtiar H Shah, Krishan K Arora, Antonio Martinez-Fuentes, Kevin J Catt.   

Abstract

The mechanism of agonist-induced activation of Pyk2 and its relationship with ERK1/2 phosphorylation was analyzed in HEK293 cells stably expressing the gonadotropin releasing hormone (GnRH) receptor. GnRH stimulation caused rapid and sustained phosphorylation of ERK1/2 and Pyk2 that was accompanied by their nuclear translocation. Pyk2 was also localized on cell membranes and at focal adhesions. Dominant negative Pyk2 (PKM) had no effect on GnRH-induced ERK1/2 phosphorylation and c-fos expression. These actions of GnRH on ERK1/2 and Pyk2 were mimicked by activation of protein kinase C (PKC) and were abolished by its inhibition. GnRH caused translocation of PKCalpha and delta, but not of epsilon, iota and lambda, to the cell membrane, as well as phosphorylation of Raf at Ser338, a major site in the activation of MEK/ERK1/2. Stimulation of HEK293 cells by EGF caused marked ERK1/2 phosphorylation that was attenuated by the selective EGFR receptor (EGF-R) kinase inhibitor, AG1478. However, GnRH-induced ERK1/2 activation was independent of EGF-R activation. These results indicate that activation of PKC is responsible for GnRH-induced phosphorylation of both ERK1/2 and Pyk2, and that Pyk2 activation does not contribute to GnRH signaling. Moreover, GnRH-induced phosphorylation of ERK1/2 and expression of c-fos in HEK293 cells is independent of Src and EGF-R transactivation, and is mediated through the PKC/Raf/MEK cascade.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943720     DOI: 10.1016/s0960-0760(03)00226-7

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  8 in total

1.  Pyk2 cytonuclear localization: mechanisms and regulation by serine dephosphorylation.

Authors:  Camille Faure; Mariana Ramos; Jean-Antoine Girault
Journal:  Cell Mol Life Sci       Date:  2012-07-17       Impact factor: 9.261

Review 2.  Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease.

Authors:  Mary E Reyland; David N M Jones
Journal:  Pharmacol Ther       Date:  2016-05-11       Impact factor: 12.310

3.  Epithelial sodium channel regulated by differential composition of a signaling complex.

Authors:  Rama Soundararajan; Daniël Melters; I-Chia Shih; Jian Wang; David Pearce
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

Review 4.  Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium.

Authors:  D Breitkreutz; L Braiman-Wiksman; N Daum; M F Denning; T Tennenbaum
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-28       Impact factor: 4.553

5.  Analysis of the calcium-dependent regulation of proline-rich tyrosine kinase 2 by gonadotropin-releasing hormone.

Authors:  Jianjun Xie; Krystal H Allen; Amelia Marguet; Kathie A Berghorn; Stuart P Bliss; Amy M Navratil; Jun Lin Guan; Mark S Roberson
Journal:  Mol Endocrinol       Date:  2008-07-17

Review 6.  Using automated imaging to interrogate gonadotrophin-releasing hormone receptor trafficking and function.

Authors:  S P Armstrong; C J Caunt; A R Finch; C A McArdle
Journal:  Mol Cell Endocrinol       Date:  2010-08-03       Impact factor: 4.102

7.  Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells.

Authors:  Marco Genua; Shi-Qiong Xu; Simone Buraschi; Stephen C Peiper; Leonard G Gomella; Antonino Belfiore; Renato V Iozzo; Andrea Morrione
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

8.  Sphingosine 1-Phosphate-Induced ICAM-1 Expression via NADPH Oxidase/ROS-Dependent NF-κB Cascade on Human Pulmonary Alveolar Epithelial Cells.

Authors:  Chih-Chung Lin; Chien-Chung Yang; Rou-Ling Cho; Chen-Yu Wang; Li-Der Hsiao; Chuen-Mao Yang
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.